z-logo
Premium
Second Generation Artificial Hydrogenases Based on the Biotin‐Avidin Technology: Improving Activity, Stability and Selectivity by Introduction of Enantiopure Amino Acid Spacers
Author(s) -
Rusbandi Untung E.,
Lo Cheikh,
Skander Myriem,
Ivanova Anita,
Creus Marc,
Humbert Nicolas,
Ward Thomas R.
Publication year - 2007
Publication title -
advanced synthesis and catalysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.541
H-Index - 155
eISSN - 1615-4169
pISSN - 1615-4150
DOI - 10.1002/adsc.200700022
Subject(s) - chemistry , streptavidin , enantiopure drug , avidin , biotin , saturated mutagenesis , selectivity , moiety , enantioselective synthesis , biotinylation , protein engineering , amino acid , stereochemistry , combinatorial chemistry , catalysis , organic chemistry , biochemistry , enzyme , mutant , gene
Abstract We report on our efforts to create efficient artificial metalloenzymes for the enantioselective hydrogenation of N ‐protected dehydroamino acids using either avidin or streptavidin as host proteins. Introduction of chiral amino acid spacers – phenylalanine or proline – between the biotin anchor and the flexible aminodiphosphine moiety 1 , combined with saturation mutagenesis at position S112X of streptavidin, affords second generation artificial hydrogenases displaying improved organic solvent tolerance, reaction rates (3‐fold) and ( S )‐selectivities (up to 95 % ee for N ‐acetamidoalanine and N ‐acetamidophenylalanine). It is shown that these artificial metalloenzymes follow Michaelis–Menten kinetics with an increased affinity for the substrate and a higher k cat than the protein‐free catalyst (compare k cat 3.06 min −1 and K M 7.38 mM for [Rh(COD) Biot‐1 ] + with k cat 12.30 min −1 and K M 4.36 mM for [Rh(COD) Biot‐( R )‐Pro‐1 ] + ⊂ WT Sav). Finally, we present a straightforward protocol using Biotin‐Sepharose to immobilize artificial metalloenzymes (>92 % ee for N ‐acetamidoalanine and N ‐acetamidophenylalanine using [Rh(COD) Biot‐( R )‐Pro‐1 ] + ⊂ Sav S112W).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here